April 20 -- Cadmus Communications Corporation announced today that the American Diabetes Association (ADA) has renewed, for an additional three years, its contract with Cadmus for the management of the commercial reprint program for the ADA's five journals. In addition to its reprint production services, Cadmus provides reprint marketing services for its scientific, technical, and medical (STM) publishing clients. The Cadmus professional marketing staff reviews article content prior to publication and proactively solicits reprints of articles on behalf of its publisher customers. The primary markets for article reprints are pharmaceutical and medical device companies that use reprints in marketing campaigns to educate physicians and healthcare providers about the benefits of their products. Reprints offer an independent, often peer-reviewed, opinion on a specific medical issue, providing valuable information to the medical community. "We are very pleased with the job that Cadmus has been doing for us," commented Peter Banks, Publisher of ADA. "Cadmus more than tripled our annual reprint income in the first year and has continued to increase sales every year. Outsourcing our reprint sales to Cadmus has also allowed us to refocus our internal resources on other initiatives." "We are very appreciative of the confidence that the ADA has placed in Cadmus to perform this critical task," said Steve Hare, President of Cadmus Publisher Services Group. "This collaboration demonstrates our commitment to provide critical resources to help our customers increase revenue and realize more value from distribution of their content."